文献速递妇科

循环代谢物与子宫内膜癌风险的前瞻性分析

Prospective analysis of circulating metabolites and endometrial cancer risk.
PubMed 文献 · Gynecol Oncol · 2021-06-05

基于EPIC队列853对病例对照的预诊断血浆,用液相色谱-质谱检测129种代谢物。调整BMI后,SM C18:0与风险正相关,甘氨酸、丝氨酸和游离肉碱与风险负相关;酯化/游离肉碱比值及短链/游离酰基肉碱比值与风险正相关。

要点

  • SM C18:0每升高1SD,子宫内膜癌风险OR为1.18(95%CI 1.05-1.33)。
  • 甘氨酸、丝氨酸、游离肉碱每升高1SD,OR分别为0.89、0.89、0.91。
  • 酯化/游离肉碱比值和短链/游离酰基肉碱比值每升高1SD,OR分别为1.14和1.12。

核心结论

  • 甘氨酸、丝氨酸、SM C18:0和游离肉碱水平变化可能代表与子宫内膜癌发展相关的特定通路。
  • 若存在因果关系,这些通路可能为子宫内膜癌预防提供新靶点。

研究设计与样本

  • 前瞻性病例对照研究,纳入欧洲癌症与营养前瞻性调查(EPIC)队列中853对病例对照的预诊断血浆样本。
  • 用液相色谱-质谱检测129种代谢物,包括酰基肉碱、氨基酸、生物胺、甘油磷脂、己糖和鞘脂。
  • 用条件logistic回归估计代谢物与子宫内膜癌风险的关联,并用bootstrap lasso方法分析代谢物集群。

主要发现

  • 调整体重指数后,SM C18:0每升高1SD与风险正相关(OR 1.18,95%CI 1.05-1.33)。
  • 甘氨酸、丝氨酸和游离肉碱每升高1SD与风险负相关(OR分别为0.89,95%CI 0.80-0.99;0.89,95%CI 0.79-1.00;0.91,95%CI 0.81-1.00)。
  • lasso方法在超过90%的bootstrap样本中选出丝氨酸、游离肉碱和两种鞘磷脂。
  • 酯化/游离肉碱比值(OR 1.14,95%CI 1.02-1.28)和短链/游离酰基肉碱比值(OR 1.12,95%CI 1.00-1.25)每升高1SD与风险正相关。
  • 进一步调整C肽或其他子宫内膜癌风险因素仅轻微改变结果。

临床怎么用

  • 这些代谢物关联提示特定代谢通路可能参与子宫内膜癌发生,但尚不能用于临床风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endometrial cancer is strongly associated with obesity and dysregulation of metabolic factors such as estrogen and insulin signaling are causal risk factors for this malignancy. To identify additional novel metabolic pathways associated with endometrial cancer we performed metabolomic analyses on pre-diagnostic plasma samples from 853 case-control pairs from the European Prospective Investigation into Cancer and Nutrition (EPIC). METHODS: A total of 129 metabolites (acylcarnitines, amino acids, biogenic amines, glycerophospholipids, hexoses, and sphingolipids) were measured by liquid chromatography-mass spectrometry. Conditional logistic regression estimated the associations of metabolites with endometrial cancer risk. An analysis focusing on clusters of metabolites using the bootstrap lasso method was also employed. RESULTS: After adjustment for body mass index, sphingomyelin [SM] C18:0 was positively (OR1SD: 1.18, 95% CI: 1.05-1.33), and glycine, serine, and free carnitine (C0) were inversely (OR1SD: 0.89, 95% CI: 0.80-0.99; OR1SD: 0.89, 95% CI: 0.79-1.00 and OR1SD: 0.91, 95% CI: 0.81-1.00, respectively) associated with endometrial cancer risk. Serine, C0 and two sphingomyelins were selected by the lasso method in >90% of the bootstrap samples. The ratio of esterified to free carnitine (OR1SD: 1.14, 95% CI: 1.02-1.28) and that of short chain to free acylcarnitines (OR1SD: 1.12, 95% CI: 1.00-1.25) were positively associated with endometrial cancer risk. Further adjustment for C-peptide or other endometrial cancer risk factors only minimally altered the results. CONCLUSION: These findings suggest that variation in levels of glycine, serine, SM C18:0 and free carnitine may represent specific pathways linked to endometrial cancer development. If causal, these pathways may offer novel targets for endometrial cancer prevention.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Dossus L, Kouloura E, Biessy C, et al. Prospective analysis of circulating metabolites and endometrial cancer risk. Gynecol Oncol. 2021. PMID: 34099314. doi:10.1016/j.ygyno.2021.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。